Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 2
2009 2
2011 1
2012 1
2021 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of basal insulin degludec 100 IU/mL versus glargine 300 IU/mL for type 1 diabetes: The single-center INEOX randomized controlled trial.
Ruiz de Adana MS, Domínguez ME, Morillas V, Colomo N, Vallejo-Mora R, Guerrero M, García-Escobar E, Carreira M, Romero-Zerbo Y, Linares F, González-Mariscal I, Bermúdez-Silva FJ, Olveira G, Rojo-Martínez G. Ruiz de Adana MS, et al. Among authors: romero zerbo y. Diabetes Res Clin Pract. 2023 Feb;196:110238. doi: 10.1016/j.diabres.2023.110238. Epub 2023 Jan 5. Diabetes Res Clin Pract. 2023. PMID: 36610544 Clinical Trial.
Insulin-like growth factor II prevents oxidative and neuronal damage in cellular and mice models of Parkinson's disease.
Martín-Montañez E, Valverde N, Ladrón de Guevara-Miranda D, Lara E, Romero-Zerbo YS, Millon C, Boraldi F, Ávila-Gámiz F, Pérez-Cano AM, Garrido-Gil P, Labandeira-Garcia JL, Santin LJ, Pavia J, Garcia-Fernandez M. Martín-Montañez E, et al. Among authors: romero zerbo ys. Redox Biol. 2021 Oct;46:102095. doi: 10.1016/j.redox.2021.102095. Epub 2021 Aug 8. Redox Biol. 2021. PMID: 34418603 Free PMC article.
Obesity-dependent cannabinoid modulation of proliferation in adult neurogenic regions.
Rivera P, Romero-Zerbo Y, Pavón FJ, Serrano A, López-Ávalos MD, Cifuentes M, Grondona JM, Bermúdez-Silva FJ, Fernández-Llebrez P, de Fonseca FR, Suárez J, Pérez-Martín M. Rivera P, et al. Among authors: romero zerbo y. Eur J Neurosci. 2011 May;33(9):1577-86. doi: 10.1111/j.1460-9568.2011.07650.x. Epub 2011 Mar 14. Eur J Neurosci. 2011. PMID: 21395869
Corrigendum to "Efficacy and safety of basal insulin degludec 100 IU/mL versus glargine 300 IU/mL for type 1 diabetes: The single-center INEOX randomized controlled trial" [Diabetes Res. Clin. Pract. 196 (2023) 110238].
Ruiz-de-Adana MS, Domínguez ME, Morillas V, Colomo N, Vallejo-Mora R, Guerrero M, García-Escobar E, Carreira M, Romero-Zerbo Y, Linares F, González-Mariscal I, Bermúdez-Silva FJ, Olveira G, Rojo-Martínez G. Ruiz-de-Adana MS, et al. Among authors: romero zerbo y. Diabetes Res Clin Pract. 2024 Apr;210:111620. doi: 10.1016/j.diabres.2024.111620. Epub 2024 Mar 21. Diabetes Res Clin Pract. 2024. PMID: 38514300 No abstract available.
Enhanced markers of oxidative stress, altered antioxidants and NADPH-oxidase activation in brains from Fragile X mental retardation 1-deficient mice, a pathological model for Fragile X syndrome.
el Bekay R, Romero-Zerbo Y, Decara J, Sanchez-Salido L, Del Arco-Herrera I, Rodríguez-de Fonseca F, de Diego-Otero Y. el Bekay R, et al. Among authors: romero zerbo y. Eur J Neurosci. 2007 Dec;26(11):3169-80. doi: 10.1111/j.1460-9568.2007.05939.x. Epub 2007 Nov 14. Eur J Neurosci. 2007. PMID: 18005058